PULSE Registry: for Patients Receiving Lutetium (177Lu) Vipivotide Tetraxetan
NCT07484269
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
753
Enrollment
INDUSTRY
Sponsor class
Conditions
Metastatic Prostate Cancer
Sponsor
Novartis Pharmaceuticals